DCL Medical Laboratories completed a recapitalization led by Thompson Street Capital Partners
October 2007 – England & Company served as the financial advisor to DCL Medical Laboratories, Inc. (“DCL”) in its acquisition by Thompson Street Capital Partners (“TSCP”).
DCL Medical Laboratories provides diagnostic testing and clinical trial testing to physicians, hospitals, and pharmaceutical companies throughout the central Midwest. Specializing in women’s health, DCL’s core business is anatomic pathology testing primarily for pap smears to detect cervical cancer. DCL is a pioneer in new product introductions such as ThinPrep pap and Human papillomavirus (HPV) testing. In addition, DCL is presently involved in more than 150 research protocols with major pharmaceutical companies for clinical trials of new women’s health care drugs and technology.